Shi J H
Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Zhonghua Jie He He Hu Xi Za Zhi. 2022 Mar 12;45(3):243-246. doi: 10.3760/cma.j.cn112147-20220110-00028.
Surgical lung biopsy (SLB) has been clearly recommended for the diagnosis of diffuse parenchymal lung disease (DPLD) in major guidelines because it provides the largest and most informative tissue samples. However, with the use of new non-invasive or minimally invasive tools in the diagnosis and treatment of DPLD, the dominance of SLB as the gold standard in the diagnosis of DPLD has been questioned, the diagnostic value of SLB for diffuse parenchymal lung should be re-evaluated.